Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Boccuzzi

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The American Journal of Cardiology|July 15, 1996
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial GroupR Waksman, A S Kosinski, L Klein, et al.
The American Journal of Cardiology|May 11, 1999
Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery diseaseC A Sueta, M Chowdhury, S J Boccuzzi, et al.
The American Journal of Cardiology|August 1, 1992
Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study GroupW S Weintraub, S J Boccuzzi, C L Brown, et al.
Archives of Internal Medicine|December 22, 1999
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival StudyS M Haffner, C M Alexander, T J Cook, et al.
Diabetes Care|November 5, 1999
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival StudyW H Herman, C M Alexander, J R Cook, et al.
The American Journal of Cardiology|November 25, 2000
Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research GroupA M Gotto, S J Boccuzzi, J R Cook, et al.
The American Journal of Cardiology|April 15, 1996
Performance standards and edge detection with computerized quantitative coronary arteriography. The Lovastatin Restenosis Trial GroupJ L Klein, S J Boccuzzi, C B Treasure, et al.
The American Journal of Cardiology|July 30, 1999
Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database?W S Weintraub, C Deaton, L Shaw, et al.
The New England Journal of Medicine|February 23, 1995
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery diseaseC B Treasure, J L Klein, W S Weintraub, et al.
The New England Journal of Medicine|November 17, 1994
Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study GroupW S Weintraub, S J Boccuzzi, J L Klein, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The American Journal of Cardiology|July 15, 1996
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial GroupR Waksman, A S Kosinski, L Klein, et al.
The American Journal of Cardiology|May 11, 1999
Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery diseaseC A Sueta, M Chowdhury, S J Boccuzzi, et al.
The American Journal of Cardiology|August 1, 1992
Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study GroupW S Weintraub, S J Boccuzzi, C L Brown, et al.
Archives of Internal Medicine|December 22, 1999
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival StudyS M Haffner, C M Alexander, T J Cook, et al.
Diabetes Care|November 5, 1999
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival StudyW H Herman, C M Alexander, J R Cook, et al.
The American Journal of Cardiology|November 25, 2000
Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research GroupA M Gotto, S J Boccuzzi, J R Cook, et al.
The American Journal of Cardiology|April 15, 1996
Performance standards and edge detection with computerized quantitative coronary arteriography. The Lovastatin Restenosis Trial GroupJ L Klein, S J Boccuzzi, C B Treasure, et al.
The American Journal of Cardiology|July 30, 1999
Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database?W S Weintraub, C Deaton, L Shaw, et al.
The New England Journal of Medicine|February 23, 1995
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery diseaseC B Treasure, J L Klein, W S Weintraub, et al.
The New England Journal of Medicine|November 17, 1994
Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study GroupW S Weintraub, S J Boccuzzi, J L Klein, et al.
Pageof 4